Vera Therapeutics, Inc.

VERA · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$152-$96-$89-$33
Dep. & Amort.$0-$4-$1$0
Deferred Tax$0$0$0-$2
Stock-Based Comp.$21$11$9$3
Change in WC$3-$6$7$4
Other Non-Cash-$6$2$7$4
Operating Cash Flow-$135-$92-$68-$24
Investing Activities
PP&E Inv.-$1-$0-$0$0
Net Acquisitions$0$0$0$1
Inv. Purchases-$712-$225-$148$0
Inv. Sales/Matur.$279$186$78$0
Other Inv. Act.$9$0-$0-$5
Investing Cash Flow-$425-$39-$71-$4
Financing Activities
Debt Repay.$0$25$20$5
Stock Issued$633$115$86$51
Stock Repurch.-$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$26-$6-$4-$2
Financing Cash Flow$607$134$102$54
Forex Effect$0$0$0$0
Net Chg. in Cash$47$2-$36$26
Supplemental Information
Beg. Cash$46$44$80$54
End Cash$93$46$44$80
Free Cash Flow-$136-$92-$68-$24